Veracyte
VCYT • NASDAQ
Veracyte is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Marc A. Stapley, with a market cap of $2.7B.
Market Cap$2.7B
Employees815.0
CEOMarc A. Stapley
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 5, 2026 · In 1 weekAfter Market Close · Q1 2026
Financials
Veracyte FAQ
Common questions about Veracyte
Veracyte is scheduled to report earnings for Q1 2026 on May 5, 2026 after market close. Analysts estimate revenue of $130.0M.
Veracyte has approximately 815 employees.